Digital Health

Virtual Clinical Trials Discussion with Charles Michael Gibson & João Bocas The Wearables Expert

João Bocas – The Wearables Expert ™ interviews Charles Michael Gibson, MD. CEO of Baim Institute for Clinical Research, (FKA Harvard Clinical Research Institute and Perfus). Professor of Medicine – Harvard Medical School. Founder & Editor in Chief WikiDoc.Org

In this episode, Joao talks about #Virtual #ClinicalTrials as opposed to traditional trials. We discuss the cost and also the main advantages in going virtual and moving to the electronic and digital world. Mike also gave amazing insights on Big Data, Data generated by #Wearables and the need to work together. Here are the questions Joao asked Dr. Gibson: 01:24 What are the forces driving the adaptation of virtual clinical trials and clinical trials? 02:52 How does a virtual clinical trial differ from a traditional clinical trial? 13:07 How do you see the future?

Connect with Dr. Gibson: LinkedIn: https://www.linkedin.com/in/cmichaelg… Twitter: https://twitter.com/CMichaelGibson Website: www.wikidoc.org

Medika Life

Medika Life is a digital Health Publication for both the medical profession and the public. Make informed decisions about your health and stay up to date with the latest developments and technological advances in the fields of medicine.

Recent Posts

How Real-World Evidence Proves the Power of Patient Engagement

Data isn’t just an asset—it’s a trust marker. In life sciences, our credibility hinges on…

2 days ago

This 5-Minute Habit Could Help Prevent a Dangerous Heart Condition.

At 7:28 a.m., the sidewalk was still damp from last night’s Seattle area rain. I…

4 days ago

How the growing trade war could affect biopharma intellectual property

President Trump said recently that the United States will announce a “major” tariff on pharmaceutical…

6 days ago

STOP! Brushing Your Teeth May Expose You to Deadly Neurotoxins

Are you sure the toothpaste you’re using is safe and won’t expose you or your…

6 days ago

‘They Won’t Help Me’: Sickest Patients Face Insurance Denials Despite Policy Fixes

In 2023, Sheldon Ekirch was diagnosed with small fiber neuropathy, which makes her limbs and…

6 days ago

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of…

2 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More